Detailed Narrative
Strong Q2 FY26 Performance and Upgraded Outlook
UPL reported a robust Q2 FY26, with revenue growing 8% YoY to ₹12,019 crore, driven by a 7% increase in volumes and a 3% favorable exchange impact. EBITDA surged 40% YoY to ₹2,205 crore, with the margin expanding by 410 basis points to 18.3%. This strong performance led to an upgraded FY26 guidance, with revenue growth now projected at 4-8% and EBITDA growth at 12-16%, reflecting management's confidence in future performance.
Improved Financial Health and Debt Reduction
The company demonstrated significant improvement in its financial health, with net debt-to-EBITDA improving from 5.4x last year to 2.7x in Q2 FY26. Net debt reduced by approximately $605 million compared to September 2024, and by $1 billion when adjusted for a $400 million perpetual bond redemption. Management expressed confidence in meeting upcoming debt obligations, including a ~$500 million repayment in March 2026, supported by a $550 million opening cash balance and expected H2 cash release of $900-1.1 billion.
Segmental Growth and Strategic Realignment
UPL Corp, the global crop protection business, grew 12% YoY, while Advanta, the seeds business, saw a strong 26% YoY growth, with its EBITDA up 57%. The Super Specialty Chemicals segment within SUPERFORM grew 18% YoY, increasing its non-agchem revenue share to ~25% from 20% last year. In a strategic move, the post-harvest business DECCO was integrated with Advanta in September 2025 to leverage synergies and enhance digitization.
Operational Efficiency and Margin Expansion
Contribution margin expanded by 420 basis points to 42% in Q2 FY26, primarily driven by an improved product mix, higher capacity utilization, and lower input costs. This operational efficiency also contributed to the strong EBITDA growth and margin expansion across platforms, including UPL SAS (India Crop Protection) which improved its EBITDA margin by 270 basis points to 22.7% despite a 10% revenue decline due to unfavorable weather.
Impact of US Tariffs and Mitigation Strategies
The company acknowledged the dynamic nature of US tariffs on Indian imports, which have increased to up to 50%, causing a negative impact of ~$3 million on H1 EBITDA. For H2, management stated that the potential negative impact is factored into the upgraded guidance. Mitigation strategies include holding inventory in bonded warehouses, adjusting product prices to reflect tariff costs, and exploring alternative supply options and local formulation in the US.
Focus on Innovation and Differentiated Solutions
UPL continues to strengthen its new product pipeline, targeting $130 million in revenue from new product launches this year, with expectations to over-deliver. The company's broad portfolio, encompassing post-patent, differentiated, and biological solutions, allows it to cater to diverse farmer needs, especially in an environment of low grower margins, driving increased interest in high-quality, low-cost post-patent solutions.